Dier Mardi Insider Trading Activity
Dier Mardi has been net-selling over the last 12 months with 0 purchases and 19 sales across 1 company.
MDGL is the most-traded position with 19 trades. The largest single transaction was a sale of MDGL for $505K on Mar 2, 2026.
Performance Scorecard
Forward stock performance after each transaction by Dier Mardi. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -11.7% | 11% | 19 |
| 90 days | — | +8.2% | 58% | 19 |
| 120 days | — | -5.0% | 58% | 19 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersMDGL · MADRIGAL PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Dier Mardi bought and sold MDGL.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Mar 6, 2026 | MDGL | Sell | 646 | $431.94 | $279K | −4.5% | CFO | |
Mar 6, 2026 | MDGL | Sell | 40 | $425.08 | $17K | −0.3% | CFO | |
Mar 6, 2026 | MDGL | Sell | 420 | $426.86 | $179K | −3.0% | CFO | |
Mar 6, 2026 | MDGL | Sell | 80 | $427.85 | $34K | −0.6% | CFO | |
Mar 6, 2026 | MDGL | Sell | 160 | $429.00 | $69K | −1.2% | CFO | |
Mar 6, 2026 | MDGL | Sell | 120 | $430.90 | $52K | −0.9% | CFO | |
Mar 6, 2026 | MDGL | Sell | 116 | $432.56 | $50K | −0.9% | CFO | |
Mar 2, 2026 | MDGL | Sell | 1,183 | $427.21 | $505K | −11.3% | CFO | |
Dec 2, 2025 | MDGL | Sell | 320 | $570.39 | $183K | −2.2% | CFO | |
Dec 2, 2025 | MDGL | Sell | 410 | $571.99 | $235K | −2.9% | CFO | |
Dec 2, 2025 | MDGL | Sell | 354 | $573.02 | $203K | −2.5% | CFO | |
Dec 2, 2025 | MDGL | Sell | 717 | $574.00 | $412K | −5.3% | CFO | |
Dec 2, 2025 | MDGL | Sell | 120 | $574.95 | $69K | −0.9% | CFO | |
Dec 2, 2025 | MDGL | Sell | 240 | $576.15 | $138K | −1.9% | CFO | |
Dec 2, 2025 | MDGL | Sell | 258 | $578.83 | $149K | −2.1% | CFO | |
Dec 2, 2025 | MDGL | Sell | 480 | $579.85 | $278K | −4.0% | CFO | |
Dec 2, 2025 | MDGL | Sell | 160 | $589.65 | $94K | −1.5% | CFO | |
Dec 2, 2025 | MDGL | Sell | 74 | $595.20 | $44K | −0.7% | CFO | |
Dec 2, 2025 | MDGL | Sell | 80 | $596.18 | $48K | −0.8% | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 19 | $3.0M |
Other insiders at MADRIGAL PHARMACEUTICALS, INC.
8 other tracked filers at MDGL.